Search

Shobha Kantamneni

Examiner (ID: 1732, Phone: (571)272-2930 , Office: P/1627 )

Most Active Art Unit
1627
Art Unit(s)
1627, 1617, 1623
Total Applications
1212
Issued Applications
306
Pending Applications
120
Abandoned Applications
793

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 11224442 [patent_doc_number] => 09452150 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-27 [patent_title] => 'Jelly composition' [patent_app_type] => utility [patent_app_number] => 11/660359 [patent_app_country] => US [patent_app_date] => 2005-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 7513 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 330 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11660359 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/660359
Jelly composition Aug 17, 2005 Issued
Array ( [id] => 5727567 [patent_doc_number] => 20060058328 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Use of N-aryl diazaspiracyclic compounds in the treatment of addiction' [patent_app_type] => utility [patent_app_number] => 11/207102 [patent_app_country] => US [patent_app_date] => 2005-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23040 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20060058328.pdf [firstpage_image] =>[orig_patent_app_number] => 11207102 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/207102
Use of N-aryl diazaspiracyclic compounds in the treatment of addiction Aug 17, 2005 Abandoned
Array ( [id] => 4693114 [patent_doc_number] => 20080085885 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-10 [patent_title] => 'Inhibition Of Voluntary Ethanol Consumption With Non-Peptidyl Melanocortin-4 Receptor Agonists' [patent_app_type] => utility [patent_app_number] => 11/660117 [patent_app_country] => US [patent_app_date] => 2005-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14844 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20080085885.pdf [firstpage_image] =>[orig_patent_app_number] => 11660117 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/660117
Inhibition Of Voluntary Ethanol Consumption With Non-Peptidyl Melanocortin-4 Receptor Agonists Aug 8, 2005 Abandoned
Array ( [id] => 7243667 [patent_doc_number] => 20050271673 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Trifunctional reagent for conjugation to a biomolecule' [patent_app_type] => utility [patent_app_number] => 11/190955 [patent_app_country] => US [patent_app_date] => 2005-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4989 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0271/20050271673.pdf [firstpage_image] =>[orig_patent_app_number] => 11190955 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/190955
Trifunctional reagent for conjugation to a biomolecule Jul 27, 2005 Abandoned
Array ( [id] => 5819951 [patent_doc_number] => 20060024264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Antimicrobial copolymers and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/186942 [patent_app_country] => US [patent_app_date] => 2005-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 20311 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20060024264.pdf [firstpage_image] =>[orig_patent_app_number] => 11186942 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/186942
Antimicrobial copolymers and uses thereof Jul 21, 2005 Abandoned
Array ( [id] => 5769329 [patent_doc_number] => 20060019967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'SARS CoV main protease inhibitors' [patent_app_type] => utility [patent_app_number] => 11/185917 [patent_app_country] => US [patent_app_date] => 2005-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 5697 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20060019967.pdf [firstpage_image] =>[orig_patent_app_number] => 11185917 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/185917
SARS CoV main protease inhibitors Jul 19, 2005 Abandoned
Array ( [id] => 4840512 [patent_doc_number] => 20080280998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Bifunctional Derivatives of Polyethylene Glycol, Their Preparation and Use' [patent_app_type] => utility [patent_app_number] => 11/570926 [patent_app_country] => US [patent_app_date] => 2005-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5642 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20080280998.pdf [firstpage_image] =>[orig_patent_app_number] => 11570926 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/570926
Bifunctional Derivatives of Polyethylene Glycol, Their Preparation and Use Jun 20, 2005 Abandoned
Array ( [id] => 7691449 [patent_doc_number] => 20070232584 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'Composition and Method for the Treatment of Tauopathies' [patent_app_type] => utility [patent_app_number] => 11/597771 [patent_app_country] => US [patent_app_date] => 2005-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14363 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20070232584.pdf [firstpage_image] =>[orig_patent_app_number] => 11597771 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/597771
Composition and method for the treatment of tauopathies May 25, 2005 Issued
Array ( [id] => 5769181 [patent_doc_number] => 20060019934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Anti-HIV-1 activity of betulinol derivatives' [patent_app_type] => utility [patent_app_number] => 11/131851 [patent_app_country] => US [patent_app_date] => 2005-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6772 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20060019934.pdf [firstpage_image] =>[orig_patent_app_number] => 11131851 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/131851
Anti-HIV-1 activity of betulinol derivatives May 17, 2005 Abandoned
Array ( [id] => 5596881 [patent_doc_number] => 20060160799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Transcription factor modulating compounds and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/115024 [patent_app_country] => US [patent_app_date] => 2005-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 58849 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20060160799.pdf [firstpage_image] =>[orig_patent_app_number] => 11115024 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/115024
Transcription factor modulating compounds and methods of use thereof Apr 24, 2005 Abandoned
Array ( [id] => 7188395 [patent_doc_number] => 20050192305 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'HIV inhibiting pyrimidine derivatives' [patent_app_type] => utility [patent_app_number] => 11/111400 [patent_app_country] => US [patent_app_date] => 2005-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15000 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20050192305.pdf [firstpage_image] =>[orig_patent_app_number] => 11111400 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/111400
HIV inhibiting pyrimidine derivatives Apr 20, 2005 Abandoned
Array ( [id] => 5259774 [patent_doc_number] => 20070213406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'Anti-Inflammatory Analgesic External Aqueus Liquid Preparation' [patent_app_type] => utility [patent_app_number] => 11/578152 [patent_app_country] => US [patent_app_date] => 2005-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2303 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20070213406.pdf [firstpage_image] =>[orig_patent_app_number] => 11578152 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/578152
Anti-Inflammatory Analgesic External Aqueus Liquid Preparation Mar 22, 2005 Abandoned
Array ( [id] => 7051301 [patent_doc_number] => 20050187188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-25 [patent_title] => 'Methods for the treatment of a traumatic central nervous system injury' [patent_app_type] => utility [patent_app_number] => 11/085889 [patent_app_country] => US [patent_app_date] => 2005-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15197 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20050187188.pdf [firstpage_image] =>[orig_patent_app_number] => 11085889 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/085889
Methods for the treatment of a traumatic central nervous system injury Mar 21, 2005 Abandoned
Array ( [id] => 7040744 [patent_doc_number] => 20050159488 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'D-serine transport antagonist for treating psychosis' [patent_app_type] => utility [patent_app_number] => 11/080551 [patent_app_country] => US [patent_app_date] => 2005-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4299 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20050159488.pdf [firstpage_image] =>[orig_patent_app_number] => 11080551 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/080551
D-serine transport antagonist for treating psychosis Mar 15, 2005 Abandoned
Array ( [id] => 5638096 [patent_doc_number] => 20060069070 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Treatment of fibrosis using FXR ligands' [patent_app_type] => utility [patent_app_number] => 11/081002 [patent_app_country] => US [patent_app_date] => 2005-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 22273 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20060069070.pdf [firstpage_image] =>[orig_patent_app_number] => 11081002 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/081002
Treatment of fibrosis using FXR ligands Mar 13, 2005 Issued
Array ( [id] => 7045210 [patent_doc_number] => 20050249805 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => ' Compositions and methods for treating hepatitis C virus (HCV) infection' [patent_app_type] => utility [patent_app_number] => 11/017531 [patent_app_country] => US [patent_app_date] => 2004-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 22173 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20050249805.pdf [firstpage_image] =>[orig_patent_app_number] => 11017531 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/017531
Compositions and methods for treating hepatitis C virus (HCV) infection Dec 17, 2004 Abandoned
Array ( [id] => 6939711 [patent_doc_number] => 20050113274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Hydrocarbyl aminohydrocarbonoates and aminohydrocarbonol hydrocarbonoates as antimicrobial and antiviral agents' [patent_app_type] => utility [patent_app_number] => 10/994591 [patent_app_country] => US [patent_app_date] => 2004-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4590 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20050113274.pdf [firstpage_image] =>[orig_patent_app_number] => 10994591 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/994591
Hydrocarbyl aminohydrocarbonoates and aminohydrocarbonol hydrocarbonoates as antimicrobial and antiviral agents Nov 18, 2004 Abandoned
10/994108 Polyamine conjugates as selective NMDA inhibitors and anti-cancer drugs Nov 18, 2004 Abandoned
Array ( [id] => 5711028 [patent_doc_number] => 20060052373 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Combination of dopamine agonists and aralkyl and aralkylidene heterocyclic lactams and imides' [patent_app_type] => utility [patent_app_number] => 10/991046 [patent_app_country] => US [patent_app_date] => 2004-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8517 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20060052373.pdf [firstpage_image] =>[orig_patent_app_number] => 10991046 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/991046
Combination of dopamine agonists and aralkyl and aralkylidene heterocyclic lactams and imides Nov 16, 2004 Abandoned
Array ( [id] => 6991479 [patent_doc_number] => 20050090516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Novel substituted imides' [patent_app_type] => utility [patent_app_number] => 10/989945 [patent_app_country] => US [patent_app_date] => 2004-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8404 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20050090516.pdf [firstpage_image] =>[orig_patent_app_number] => 10989945 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/989945
Substituted imides Nov 15, 2004 Issued
Menu